When does the cenobamate (Xcopri) patent expire?
The patent-expiry date for cenobamate depends on which specific patent(s) covering Xcopri are being tracked, and whether you mean “first generic entry,” “full patent expiry,” or “market exclusivity.” The information provided here does not include any specific patent numbers, filing dates, jurisdiction, or an exclusivity/registration timeline, so the exact expiry date can’t be determined from the available data.
Which country’s patent expiry date matters for cenobamate?
Patent expiry is country-specific. Cenobamate’s U.S. patent term may differ from Europe/UK/other jurisdictions due to different patent families, term adjustments, and patent-extension rules. To give an accurate expiry date, you need the jurisdiction (e.g., United States vs. EP/UK) and ideally the patent family you care about.
How do you find the right “expiry date” for cenobamate?
People often conflate several different dates:
- Patent expiration for a particular listed patent in a jurisdiction (the “end” of that patent’s enforceable term).
- Regulatory exclusivity periods (which can delay generic or biosimilar entry even if a patent is near/at expiration).
- Launch or approval timing for competitors (which depends on patent litigation outcomes and regulatory submissions).
What I need to give you a specific cenobamate expiry date
Share one of the following, and I’ll compute/identify the relevant expiry date from that context:
- The jurisdiction (US, EU, UK, etc.)
- The patent number or publication (or a link to the listing)
- Whether you mean “first allowed generic entry” (regulatory + patent landscape) or the “end of a specific patent term”
Sources: none cited (no patent/exclusivity data was provided in the prompt).